Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
Anticancer Research|December 7, 2016
Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic CancerDimitrios Pectasides, Vasiliki Kotoula, George Papaxoinis, et al.
Anticancer Research|October 13, 2012
Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxelIppokratis Korantzis, Konstantine T Kalogeras, George Papaxoinis, et al.
Cancer Genomics & Proteomics|April 30, 2020
Prognostic Biomarkers in Early-stage Gastric Adenocarcinoma Treated With Adjuvant ChemoradiotherapyEirini Pectasides, Ioannis Chatzidakis, Vassiliki Kotoula, et al.
Clinical Breast Cancer|April 8, 2014
Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancerGeorge Pentheroudakis, Vassiliki Kotoula, George Kouvatseas, et al.
BMC Cancer|August 8, 2012
Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS)Vassiliki Kotoula, Dimitrios Krikelis, Vasilios Karavasilis, et al.
Breast Cancer Research : BCR|November 14, 2012
The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trialHelena Linardou, Konstantine T Kalogeras, Ralf Kronenwett, et al.
Pharmacogenomics|November 15, 2012
Association of ERCC1 SNPs with outcome in platinum-treated patients with advanced urothelial cancer: a Hellenic Cooperative Oncology Group studyNikitas Nikitas, Alexandra Karadimou, Eliza Tsitoura, et al.
Anticancer Research|October 3, 2014
Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology GroupVasilios Karavasilis, Paris Kosmidis, Konstantinos N Syrigos, et al.
Cancer Genomics & Proteomics|February 20, 2021
Androgen Receptor and PIM1 Expression in Tumor Tissue of Patients With Triple-negative Breast CancerAliki Ntzifa, Areti Strati, Georgia-Angeliki Koliou, et al.
Anticancer Research|August 6, 2005
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II studyDimosthenis V Skarlos, Haralabos P Kalofonos, George Fountzilas, et al.
Pageof 19